Iniciar sesión Regístrese gratis

Panbela Therapeutics Ingresos

¿Qué es el Ingresos de Panbela Therapeutics?

El Ingresos de Panbela Therapeutics Inc. es $0.00

¿Cuál es la definición de Ingresos?



Los ingresos son las ganancias que una empresa tiene de sus actividades comerciales normales, generalmente de la venta de bienes y servicios a los clientes.

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Ingresos de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics

¿Qué hace Panbela Therapeutics?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Empresas con ingresos similar a Panbela Therapeutics